FDA Puts Caffeine Labels on Its Must-Do List

FDA caffeine labeling guidance lands on the agency's priority list as Celsius and Alani Nu face scrutiny over undisclosed health risks.

The FDA just made caffeine labeling guidance an official regulatory priority, and the timing is not subtle. Celsius, Alani Nu, and other energy drink brands are already under fire for allegedly hiding health risks from consumers. The pressure is now institutional, not just legal.

TLDR

  • FDA formally added caffeine labeling to its regulatory priority agenda.
  • Celsius and Alani Nu face mounting legal scrutiny over health risk disclosures.
  • Guidance could force energy drink brands to rethink label architecture fast.
  • Consumer transparency expectations are now backed by federal regulatory momentum.
  • Operators sourcing high-caffeine ingredients should monitor this guidance closely.

The FDA’s decision to prioritize caffeine labeling guidance signals a meaningful shift in how regulators view the energy drink category. Reported by Food Dive, the move follows intensifying scrutiny of brands like Celsius and Alani Nu, both accused of failing to adequately disclose caffeine-related health risks to consumers.

Significant.

FDA Caffeine Labeling Guidance Puts Energy Brands on Notice

The energy drink market has long operated in a labeling gray zone. Caffeine content disclosures have been inconsistent across products, and no binding federal standard has forced uniformity. That gap is now squarely in the FDA’s sights.

Celsius, one of the category’s fastest-growing brands, has faced lawsuits alleging its products contain undisclosed health risks tied to caffeine levels. Alani Nu, popular with younger consumers, has drawn similar scrutiny. Both cases reflect a broader pattern: brands scaling quickly while labeling practices lag behind.

What Operators and Suppliers Should Watch

For manufacturers and co-packers working in the functional beverage space, FDA guidance, once finalized, could establish specific thresholds, warning language requirements, or serving-size disclosure rules. Any of those outcomes would ripple through formulation, packaging, and compliance workflows.

Retailers carrying high-caffeine products face their own exposure. Shelf placement and marketing claims tied to energy and performance may require revisiting if guidance tightens disclosure standards. Brands already investing in proactive transparency, like those voluntarily listing caffeine per serving prominently, are positioned ahead of the curve.

The FDA’s priority designation does not guarantee a final rule on any set timeline. However, it does signal that inaction is no longer an option. Brands still treating caffeine disclosure as optional are now operating against a federal clock. For context on how clean-label leaders are approaching functional ingredient transparency, see thefutureoffood.org.

The leaders are already moving. The question is how far behind the laggards will be when the guidance drops.


Source: Food Dive. https://www.fooddive.com/news/caffeine-labeling-fda-guidance-celsius-alani-nu/824355/

Leave a Reply

Your email address will not be published. Required fields are marked *